<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9724088" created="28/04/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9724088</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="peripheral_T_lymphocyte" sem="Cell_natural">Peripheral T <term id="T2" lex="lymphocyte" sem="Cell_natural">lymphocytes</term></term> from <term id="T3" lex="woman" sem="Multicellular_organism_natural">women</term> with breast cancer exhibit abnormal protein expression of <term id="T4" lex="several_signaling_molecule" sem="Protein_family_or_group">several signaling molecules</term>.</sentence>
<event id="E1">
<type class="Gene_expression"/>
<theme idref="T4"/>
<clue><clueLoc>Peripheral T lymphocytes</clueLoc> from women with breast cancer exhibit abnormal protein <clueType>expression</clueType> <linkTheme>of</linkTheme> several signaling molecules.</clue>
</event>
<event id="E28">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<clue>Peripheral T lymphocytes from women with breast cancer <clueType>exhibit abnormal</clueType> protein expression of several signaling molecules.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">We examined signaling molecules of <term id="T5" lex="peripheral_blood_T_lymphocyte" sem="Cell_natural">peripheral blood T lymphocytes</term> obtained from women with <term id="T6" lex="breast_cancer" sem="Other">breast cancer</term>.</sentence>
<sentence id="S3">In 6 of 14 <term id="T7" lex="patient" sem="Multicellular_organism_natural">patients</term>, <term id="T8" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> displayed an impaired ability to translocate <term id="T9" lex="NFeB_p65" sem="Protein_molecule">NFeB p65</term> (<term id="T10" lex="Rel-A" sem="Protein_molecule">Rel-A</term>) following activation by <term id="A1" sem="Protein_molecule">anti-CD3</term> and <term id="T11" lex="IL-2" sem="Protein_molecule">IL-2</term>.</sentence>
<event KT="Other" id="E2">
<type class="Physiological_process"/>
<theme idref="T8"/>
<cause idref="A1"/>
<clue>In 6 of 14 patients, T lymphocytes displayed an impaired ability to translocate NFeB p65 (Rel-A) following <clueType>activation</clueType> <linkCause>by</linkCause> anti-CD3 and IL-2.</clue>
</event>
<event KT="Other" id="E3">
<type class="Physiological_process"/>
<theme idref="T8"/>
<cause idref="T11"/>
<clue>In 6 of 14 patients, T lymphocytes displayed an impaired ability to translocate NFeB p65 (Rel-A) following <clueType>activation</clueType> <linkCause>by</linkCause> anti-CD3 and IL-2.</clue>
</event>
<event KT="Analysis" id="E31">
<type class="Negative_regulation"/>
<theme idref="E4"/>
<cause idref="E2"/>
<clue>In 6 of 14 patients, <clueLoc>T lymphocytes</clueLoc> <clueKT>displayed</clueKT> an <clueType>impaired</clueType> ability to translocate NFeB p65 (Rel-A) <linkCause>following</linkCause> activation by anti-CD3 and IL-2.</clue>
</event>
<event KT="Analysis" id="E32">
<type class="Negative_regulation"/>
<theme idref="E5"/>
<cause idref="E3"/>
<clue>In 6 of 14 patients, <clueLoc>T lymphocytes</clueLoc> <clueKT>displayed</clueKT> an <clueType>impaired</clueType> ability to translocate NFeB p65 (Rel-A) <linkCause>following</linkCause> activation by anti-CD3 and IL-2.</clue>
</event>
<event CL="L2" KT="Analysis" id="E4">
<type class="Localization"/>
<theme idref="T10"/>
<clue>In 6 of 14 patients, <clueLoc>T lymphocytes</clueLoc> displayed an impaired <clueKT><clueCL>ability</clueCL></clueKT> to <clueType>translocate</clueType> NFeB p65 (Rel-A) following activation by anti-CD3 and IL-2.</clue>
</event>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="E2"/>
<clue>In 6 of 14 patients, T lymphocytes displayed an impaired ability to translocate NFeB p65 (Rel-A) <linkCause>following</linkCause> activation by anti-CD3 and IL-2.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Other" id="E33">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="E3"/>
<clue>In 6 of 14 patients, T lymphocytes displayed an impaired ability to translocate NFeB p65 (Rel-A) <linkCause>following</linkCause> activation by anti-CD3 and IL-2.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S4">This observation was made despite normal <term id="T12" lex="cytoplasmic_level" sem="Other">cytoplasmic levels</term> of the <term id="T13" lex="Rel-A_protein" sem="Protein_molecule">Rel-A protein</term>.</sentence>
<event KT="Analysis" id="E29">
<type class="Gene_expression"/>
<theme idref="T13"/>
<clue>This observation was made despite <clueKT>normal</clueKT> <clueLoc>cytoplasmic</clueLoc> <clueType>levels</clueType> <linkTheme>of</linkTheme> the Rel-A protein.</clue>
</event>
<sentence id="S5">We also detected abnormally low levels of the <term id="T14" lex="signaling_molecule" sem="Protein_family_or_group">signaling molecules</term> <term id="T15" lex="T-cell_receptor_(TCR)-zeta" sem="Protein_molecule">T-cell receptor (TCR)-zeta</term>, <term id="T16" lex="ZAP-70" sem="Protein_molecule">ZAP-70</term> and <term id="T17" lex="p56lck" sem="Protein_molecule">p56lck</term> in 4 of 14 <term id="T18" lex="breast_cancer" sem="Other">breast cancer</term> <term id="T19" lex="patient" sem="Multicellular_organism_natural">patients</term>, i.e., defects in <term id="T20" lex="T-cell_signaling_molecule" sem="Protein_family_or_group">T-cell <term id="T21" lex="signaling_molecule" sem="Protein_family_or_group">signaling molecules</term></term>.</sentence>
<event Manner="Low" id="E6">
<type class="Negative_regulation"/>
<theme idref="T15"/>
<clue>We also <clueType><clueKT>detected</clueKT></clueType> <clueManner>abnormally</clueManner> <clueType><clueManner>low levels</clueManner></clueType> <linkTheme>of</linkTheme> <corefTheme>the signaling molecules</corefTheme> T-cell receptor (TCR)-zeta, ZAP-70 and p56lck in 4 of 14 breast cancer patients, i.e., defects in T-cell signaling molecules.</clue>
</event>
<event Manner="Low" id="E7">
<type class="Negative_regulation"/>
<theme idref="T16"/>
<clue>We also <clueType><clueKT>detected</clueKT></clueType> <clueManner>abnormally</clueManner> <clueType><clueManner>low levels</clueManner></clueType> <linkTheme>of</linkTheme> <corefTheme>the signaling molecules</corefTheme> T-cell receptor (TCR)-zeta, ZAP-70 and p56lck in 4 of 14 breast cancer patients, i.e., defects in T-cell signaling molecules.</clue>
</event>
<event Manner="Low" id="E8">
<type class="Negative_regulation"/>
<theme idref="T17"/>
<clue>We also <clueType><clueKT>detected</clueKT></clueType> <clueManner>abnormally</clueManner> <clueType><clueManner>low levels</clueManner></clueType> <linkTheme>of</linkTheme> <corefTheme>the signaling molecules</corefTheme> T-cell receptor (TCR)-zeta, ZAP-70 and p56lck in 4 of 14 breast cancer patients, i.e., defects in T-cell signaling molecules.</clue>
</event>
<event id="E30">
<type class="Negative_regulation"/>
<theme idref="T20"/>
<clue>We also <clueKT>detected</clueKT> abnormally low levels of the signaling molecules T-cell receptor (TCR)-zeta, ZAP-70 and p56lck in 4 of 14 breast cancer patients, i.e., <clueType>defects</clueType> <linkTheme>in</linkTheme> T-cell signaling molecules.</clue>
</event>
<sentence id="S6"><term id="T22" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term> from 6 of the 14 <term id="T23" lex="patient" sem="Multicellular_organism_natural">patients</term> also exhibited an increased expression of the dual <term id="T24" lex="specificity_phosphatase" sem="Protein_family_or_group">specificity phosphatase</term>, <term id="T25" lex="map_kinase_phosphatase-1" sem="Protein_molecule">map kinase phosphatase-1</term> (<term id="T26" lex="MKP-1" sem="Protein_molecule">MKP-1</term>).</sentence>
<event KT="Analysis" id="E9">
<type class="Positive_regulation"/>
<theme idref="E10"/>
<clue><clueLoc>T lymphocytes</clueLoc> from 6 of the 14 patients also <clueKT>exhibited</clueKT> an <clueType>increased</clueType> expression of the dual specificity phosphatase, map kinase phosphatase-1 (MKP-1).</clue>
</event>
<event KT="Other" id="E10">
<type class="Gene_expression"/>
<theme idref="T26"/>
<clue>T lymphocytes from 6 of the 14 patients also exhibited an increased <clueType>expression</clueType> <linkTheme>of</linkTheme> the <corefTheme>dual specificity phosphatase</corefTheme>, map kinase phosphatase-1 (MKP-1).</clue>
</event>
<sentence id="S7"><term id="T27" lex="MKP-1" sem="Protein_molecule">MKP-1</term> inactivates <term id="T28" lex="MAP_kinase" sem="Protein_family_or_group">MAP kinase</term> and therefore may interfere with the activation of <term id="T29" lex="c-jun" sem="DNA_domain_or_region">c-jun</term> and <term id="T30" lex="c-fos" sem="DNA_domain_or_region">c-fos</term>.</sentence>
<event id="E11">
<type class="Negative_regulation"/>
<theme idref="T28"/>
<cause idref="T27"/>
<clue>MKP-1 <clueType>inactivates</clueType> MAP kinase and therefore may interfere with the activation of c-jun and c-fos.</clue>
</event>
<event CL="L1" KT="Analysis" id="E12" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E14"/>
<cause idref="E11"/>
<clue>MKP-1 inactivates MAP kinase and <corefCause>therefore</corefCause> <clueKT><clueCL>may</clueCL></clueKT> <clueType>interfere</clueType> <linkTheme>with</linkTheme> the activation of c-jun and c-fos.</clue>
</event>
<event CL="L1" KT="Analysis" id="E13" uncertainty="probable">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<cause idref="E11"/>
<clue>MKP-1 inactivates MAP kinase and <corefCause>therefore</corefCause> <clueKT><clueCL>may</clueCL></clueKT> <clueType>interfere</clueType> <linkTheme>with</linkTheme> the activation of c-jun and c-fos.</clue>
</event>
<event KT="Other" id="E14">
<type class="Positive_regulation"/>
<theme idref="T29"/>
<clue>MKP-1 inactivates MAP kinase and therefore may interfere with the <clueType>activation</clueType> <linkTheme>of</linkTheme> c-jun and c-fos.</clue>
</event>
<event KT="Other" id="E15">
<type class="Positive_regulation"/>
<theme idref="T30"/>
<clue>MKP-1 inactivates MAP kinase and therefore may interfere with the <clueType>activation</clueType> <linkTheme>of</linkTheme> c-jun and c-fos.</clue>
<comment>CAUTION: S8, &quot;I or more&quot;, correctly &quot;1 or more&quot;</comment></event>
<sentence id="S8">Abnormalities of I or more <term id="T31" lex="signaling_molecule" sem="Protein_family_or_group">signaling molecules</term> were found in 9 of 14 <term id="T32" lex="patient" sem="Multicellular_organism_natural">patients</term>; however, only 3 <term id="T33" lex="patient" sem="Multicellular_organism_natural">patients</term> had <term id="T34" lex="T_cell" sem="Cell_natural">T cells</term> that exhibited all 5 defects.</sentence>
<sentence id="S9">Our data have implications for the detection of potentially dysfunctional <term id="T35" lex="T_cell" sem="Cell_natural">T cells</term> in <term id="T36" lex="patient" sem="Multicellular_organism_natural">patients</term> with <term id="T37" lex="cancer" sem="Other">cancer</term>.</sentence>
<sentence id="S10">For example, the analysis of only 1 <term id="T38" lex="signaling_molecule" sem="Protein_family_or_group">signaling molecule</term> may allow <term id="T39" lex="patient" sem="Multicellular_organism_natural">patients</term> with significant defects in T-cell signaling to go unnoticed.</sentence>
<sentence id="S11">Finally, despite impaired <term id="T40" lex="Rel-A_translocation" sem="Other"><term id="T41" lex="Rel-A" sem="Protein_molecule">Rel-A</term> translocation</term>, <term id="T42" lex="T_cell" sem="Cell_natural">T cells</term> were capable of transcribing <term id="A3" sem="DNA_domain_or_region"><term id="T43" lex="IL-2" sem="Protein_molecule">IL-2</term></term>.</sentence>
<event KT="Other" id="E16">
<type class="Localization"/>
<theme idref="T41"/>
<clue>Finally, despite impaired Rel-A <clueType>translocation</clueType>, T cells were capable of transcribing IL-2.</clue>
</event>
<event id="E17">
<type class="Negative_regulation"/>
<theme idref="E16"/>
<clue>Finally, despite <clueType>impaired</clueType> Rel-A translocation, T cells were capable of transcribing IL-2.</clue>
</event>
<event KT="Other" id="E18">
<type class="Transcription"/>
<theme idref="A3"/>
<clue>Finally, despite impaired Rel-A translocation, <clueLoc>T cells</clueLoc> were capable of <clueType>transcribing</clueType> IL-2.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E19">
<type class="Negative_regulation"/>
<theme idref="E18"/>
<cause idref="E17"/>
<clue>Finally, <linkCause><cluePolarity>despite</cluePolarity></linkCause> impaired Rel-A translocation, T cells were <clueKT><clueCL>capable</clueCL></clueKT> of transcribing IL-2.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S12">Impairments in the translocation of <term id="T44" lex="Rel-B" sem="Protein_molecule">Rel-B</term> and <term id="T45" lex="c-Rel" sem="Protein_molecule">c-Rel</term> further suggest that the <term id="T46" lex="NFKB_family_member" sem="Protein_family_or_group">NFKB family members</term> <term id="T47" lex="Rel-A" sem="Protein_molecule">Rel-A</term>, <term id="T48" lex="Rel-B" sem="Protein_molecule">Rel-B</term> and <term id="T49" lex="c-Rel" sem="Protein_molecule">c-Rel</term> are not required for the transcription of <term id="A4" sem="DNA_domain_or_region"><term id="T50" lex="IL-2" sem="Protein_molecule">IL-2</term></term> in the <term id="T51" lex="peripheral_T_lymphocyte" sem="Cell_natural">peripheral <term id="T52" lex="T_lymphocyte" sem="Cell_natural">T lymphocytes</term></term> of <term id="T53" lex="patient" sem="Multicellular_organism_natural">patients</term> with <term id="T54" lex="breast_cancer" sem="Other">breast cancer</term>.</sentence>
<event KT="Other" id="E20">
<type class="Localization"/>
<theme idref="T44"/>
<clue>Impairments in the <clueType>translocation</clueType> <linkTheme>of</linkTheme> Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.</clue>
</event>
<event KT="Other" id="E21">
<type class="Localization"/>
<theme idref="T45"/>
<clue>Impairments in the <clueType>translocation</clueType> <linkTheme>of</linkTheme> Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.</clue>
</event>
<event KT="Other" id="E22">
<type class="Negative_regulation"/>
<theme idref="E20"/>
<clue><clueType>Impairments</clueType> <linkTheme>in</linkTheme> the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.</clue>
</event>
<event KT="Other" id="E23">
<type class="Negative_regulation"/>
<theme idref="E21"/>
<clue><clueType>Impairments</clueType> <linkTheme>in</linkTheme> the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the transcription of IL-2 in the peripheral T lymphocytes of patients with breast cancer.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E24" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E27"/>
<cause idref="T47"/>
<clue>Impairments in the translocation of Rel-B and c-Rel further <clueKT><clueCL>suggest</clueCL></clueKT> that the <corefCause>NFKB family members</corefCause> Rel-A, Rel-B and c-Rel are <cluePolarity>not</cluePolarity> <clueType>required</clueType> <linkTheme>for</linkTheme> the transcription of IL-2 <clueLoc>in the peripheral T lymphocytes</clueLoc> of patients with breast cancer.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E25" uncertainty="probable">
<type class="Regulation"/>
<theme idref="E27"/>
<cause idref="T47"/>
<clue>Impairments in the translocation of Rel-B and c-Rel further <clueKT><clueCL>suggest</clueCL></clueKT> that the <corefCause>NFKB family members</corefCause> Rel-A, Rel-B and c-Rel are <cluePolarity>not</cluePolarity> <clueType>required</clueType> <linkTheme>for</linkTheme> the transcription of IL-2 <clueLoc>in the peripheral T lymphocytes</clueLoc> of patients with breast cancer.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E26">
<type class="Regulation"/>
<theme idref="E27"/>
<cause idref="T47"/>
<clue>Impairments in the translocation of Rel-B and c-Rel further <clueKT><clueCL>suggest</clueCL></clueKT> that the <corefCause>NFKB family members</corefCause> Rel-A, Rel-B and c-Rel are <cluePolarity>not</cluePolarity> <clueType>required</clueType> <linkTheme>for</linkTheme> the transcription of IL-2 <clueLoc>in the peripheral T lymphocytes</clueLoc> of patients with breast cancer.</clue>
</event>
<event KT="Other" id="E27">
<type class="Transcription"/>
<theme idref="A4"/>
<clue>Impairments in the translocation of Rel-B and c-Rel further suggest that the NFKB family members Rel-A, Rel-B and c-Rel are not required for the <clueType>transcription</clueType> <linkTheme>of</linkTheme> IL-2 in the peripheral T lymphocytes of patients with breast cancer.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
